Company Filing History:
Years Active: 2013
Title: Chuanliang Liu: Innovator in Herpes Virus Treatment
Introduction
Chuanliang Liu is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of medical science, particularly in the development of vaccines for viral infections. His innovative work focuses on the prevention and treatment of herpes simplex virus infections.
Latest Patents
Chuanliang Liu holds a patent for a vaccine aimed at the treatment and prevention of herpes simplex virus infection. The patent details methods and compositions that provide antigenic peptides and pharmaceutical compositions. These compositions comprise complexes of antigenic peptides and adjuvants that can activate an immune response against herpes viruses. The invention also outlines methods for producing the antigenic peptides and their complexes, as well as the pharmaceutical compositions' methods of use.
Career Highlights
Liu's career is marked by his role at Agenus Inc., where he has been instrumental in advancing research and development in immunotherapy. His work has contributed to the understanding of how to effectively combat herpes virus infections through innovative vaccine strategies.
Collaborations
Chuanliang Liu has collaborated with esteemed colleagues, including Alemseged Truneh and Daniel Lewis Levey. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments.
Conclusion
Chuanliang Liu's contributions to the field of vaccine development, particularly for herpes simplex virus infections, highlight his innovative spirit and dedication to medical science. His work continues to pave the way for advancements in immunotherapy and viral infection treatment.